KLRC1 and non-Hodgkin lymphoma: Together, these and our data provide evidence that NKG2A+ NK cells can, to some extent, prevent the EBV-induced transformation and that the EBV-mediated inhibition of NKG2A+ NK cells subsequently increases the risk to develop EBV+HL and EBV+nHL.